4//SEC Filing
Gergen Mark J 4
Accession 0000950170-24-131665
CIK 0001661460other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 7:39 PM ET
Size
8.3 KB
Accession
0000950170-24-131665
Insider Transaction Report
Form 4
Gergen Mark J
DirectorExecutive Chairman
Transactions
- Sale
Common Stock
2024-11-26$9.27/sh−30,000$278,100→ 651,291 total - Exercise/Conversion
Common Stock
2024-11-26$2.78/sh+30,000$83,430→ 681,291 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-11-26−30,000→ 126,372 totalExercise: $2.78Exp: 2028-03-01→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The option exercise and sale reported in this Form 4 were effected pusuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.
- [F2]The stock option is fully vested and exerciseable.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001373110
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 7:39 PM ET
- Size
- 8.3 KB